These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31293304)

  • 1. Camurati-Engelmann Disease with Good Treatment Response to Losartan.
    Abdulla MC
    Indian J Nucl Med; 2019; 34(3):223-225. PubMed ID: 31293304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camurati-Engelmann disease: a case report from sub-Saharan Africa.
    Mwasamwaja AO; Mkwizu EW; Shao ER; Kalambo CF; Lyaruu I; Hamel BC
    Oxf Med Case Reports; 2018 Jul; 2018(7):omy036. PubMed ID: 30034812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a single case observation.
    Simsek-Kiper PO; Dikoglu E; Campos-Xavier B; Utine GE; Bonafe L; Unger S; Boduroglu K; Superti-Furga A
    Am J Med Genet A; 2014 Oct; 164A(10):2667-71. PubMed ID: 25099136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proband and the Brother.
    B S; Kotha JP
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camurati-Engelmann Disease Complicated by Hypopituitarism: Management Challenges and Literature Review of Outcomes With Bisphosphonates.
    Das L; Dhiman V; Dutta P; Sood A; Prakash M; Kaur S; Steenackers E; Hendrickx G; Dayal D; Van Hul W; Bhadada SK
    AACE Clin Case Rep; 2022; 8(2):58-64. PubMed ID: 35415221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease.
    Agarwal K; Rajan R; Paul J; Cherian KE; Kapoor N; Paul TV
    AACE Clin Case Rep; 2022; 8(2):54-57. PubMed ID: 35415233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camurati-Engelmann disease (progressive diaphyseal dysplasia): reports of an Indian kindred.
    Bhadada SK; Sridhar S; Steenackers E; Dhiman V; Mortier G; Bhansali A; Van Hul W
    Calcif Tissue Int; 2014 Feb; 94(2):240-7. PubMed ID: 24154985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.
    Bondestam J; Mäyränpää MK; Ikegawa S; Marttinen E; Kröger H; Mäkitie O
    Clin Rheumatol; 2007 Oct; 26(10):1773-7. PubMed ID: 17206397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.
    Cui L; Li Q; Guan W; Yu W; Li X; Xia W; Jiang Y
    Front Endocrinol (Lausanne); 2022; 13():882144. PubMed ID: 35784539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant Improvement After Surgery for a Symptomatic Osteoblastoma in a Patient with Camurati-Engelmann Disease: Case Report and Literature Review.
    Yonezawa H; Hayashi K; Yamamoto N; Takeuchi A; Tada K; Miwa S; Igarashi K; Kimura H; Aoki Y; Morinaga S; Araki Y; Asano Y; Sakurakichi K; Ikeda H; Nojima T; Tsuchiya H
    Calcif Tissue Int; 2021 Jun; 108(6):819-824. PubMed ID: 33555353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camurati-Engelmann Disease: A Case-Based Review About an Ultrarare Bone Dysplasia.
    Klemm P; Aykara I; Lange U
    Eur J Rheumatol; 2023 Jan; 10(1):34-38. PubMed ID: 36880809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camurati-Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family.
    Simsek S; Janssens K; Kwee ML; Van Hul W; Veenstra J; Netelenbos JC
    Osteoporos Int; 2005 Sep; 16(9):1167-70. PubMed ID: 15959620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camurati-Engelmann Disease.
    Van Hul W; Boudin E; Vanhoenacker FM; Mortier G
    Calcif Tissue Int; 2019 May; 104(5):554-560. PubMed ID: 30721323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first Korean case of Camurati-Engelmann disease (progressive diaphyseal dysplasia) confirmed by TGFB1 gene mutation analysis.
    Park SJ; Yoon CS; Park HW; Choi JR; Chung JS; Lee KA
    J Korean Med Sci; 2009 Aug; 24(4):737-40. PubMed ID: 19654961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camurati-Engelmann disease--a rare cause of bone pain.
    Mundra V; Taxel P
    Conn Med; 2012 Jan; 76(1):33-7. PubMed ID: 22372177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camurati-engelmann disease association with hypogonadism and primary hypothyroidism.
    Low SF; Abu Bakar N; Ngiu CS
    Iran Red Crescent Med J; 2014 Aug; 16(8):e9481. PubMed ID: 25389497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment outcomes in Camurati-Engelmann disease: A case series.
    Kim YM; Kang E; Choi JH; Kim GH; Yoo HW; Lee BH
    Medicine (Baltimore); 2018 Apr; 97(14):e0309. PubMed ID: 29620655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal Dysplasia Presenting as a Neuromuscular Disorder - Report of a Family with Camurati-Engelmann Syndrome.
    Plaiasu V; Costin A
    Maedica (Bucur); 2015 Mar; 10(1):48-51. PubMed ID: 26225150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.
    Whyte MP; Totty WG; Novack DV; Zhang X; Wenkert D; Mumm S
    J Bone Miner Res; 2011 May; 26(5):920-33. PubMed ID: 21541994
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.